LEQVIO (inclisiran sodium) Novartis Patent: 10,590,418 Expiration: Jul 19, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug Pa…
Drug Patent Expirations for the Week of July 17, 2022 Read Post »
Annual Drug Patent Expirations for LIVMARLI Livmarli is a drug marketed by Mirum and is included in one NDA. There are two patents protecting this drug. This drug has thirty-two…
The post New patent for MIRUM drug LIVMARLI appeared first on DrugPatentW…
Annual Drug Patent Expirations for COTELLIC Cotellic is a drug marketed by Genentech Inc and is included in one NDA. It is available from one supplier. There are six patents…
The post New patent for Genentech Inc drug COTELLIC appeared first on DrugPat…
Palbociclib is the generic ingredient in one branded drug marketed by Pfizer and is included in two NDAs. There are six patents protecting this compound. Drug patent litigation for PALBOCICLIB.…
The post New tentative approval for Eugia Pharma drug pal…
New tentative approval for Eugia Pharma drug palbociclib Read Post »
Annual Drug Patent Expirations for LYMPHOSEEK+KIT Lymphoseek Kit is a drug marketed by Cardinal Health 414 and is included in one NDA. It is available from one supplier. There are…
The post New patent for Cardinal Health drug LYMPHOSEEK KIT appeared fi…
New patent for Cardinal Health drug LYMPHOSEEK KIT Read Post »
This chart shows the pharmaceutical companies with the most pellets dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most pellets dosed drugs…
The post Which pharmaceutical companies have the most pell…
Which pharmaceutical companies have the most pellets dosed drugs? Read Post »
Annual Drug Patent Expirations for LYBALVI Lybalvi is a drug marketed by Alkermes Inc and is included in one NDA. It is available from one supplier. There are nine patents…
The post New patent for Alkermes Inc drug LYBALVI appeared first on DrugPatentW…
Palbociclib is the generic ingredient in one branded drug marketed by Pfizer and is included in two NDAs. There are six patents protecting this compound. Drug patent litigation for PALBOCICLIB.…
The post New tentative approval for Eugia Pharma drug pal…
New tentative approval for Eugia Pharma drug palbociclib Read Post »
This chart shows the companies which have received the most New Combination exclusivities in the past five years. New Combinations are one of the categories for which the FDA grants…
The post Pharmaceutical companies with the most ‘New Combination’ dru…
Pharmaceutical companies with the most ‘New Combination’ drugs Read Post »
This chart shows the companies which have received the most New Combination exclusivities in the past five years. New Combinations are one of the categories for which the FDA grants…
The post Pharmaceutical companies with the most ‘New Combination’ dru…
Pharmaceutical companies with the most ‘New Combination’ drugs Read Post »
Get new actionable insights and updates from BiotechBlog
